Canada · Delayed Price · Currency is CAD Republic Technologies Statistics
Total Valuation
CSE:DOCT has a market cap or net worth of CAD 5.74 million. The enterprise value is 16.95 million.
| Market Cap | 5.74M |
| Enterprise Value | 16.95M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:DOCT has 32.79 million shares outstanding. The number of shares has increased by 110.66% in one year.
| Current Share Class | 32.79M |
| Shares Outstanding | 32.79M |
| Shares Change (YoY) | +110.66% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.99% |
| Owned by Institutions (%) | n/a |
| Float | 17.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -1,596.37 |
| PB Ratio | -1.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.90
| Current Ratio | 5.90 |
| Quick Ratio | 1.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.01 |
| Interest Coverage | -0.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.15% |
| Return on Invested Capital (ROIC) | -30.09% |
| Return on Capital Employed (ROCE) | -26.98% |
| Weighted Average Cost of Capital (WACC) | 15.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -223,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.31% in the last 52 weeks. The beta is 2.54, so CSE:DOCT's price volatility has been higher than the market average.
| Beta (5Y) | 2.54 |
| 52-Week Price Change | -71.31% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 56.36 |
| Average Volume (20 Days) | 7,355 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:DOCT had revenue of CAD -3,595 and -7.19 million in losses. Loss per share was -0.22.
| Revenue | -3,595 |
| Gross Profit | -330,324 |
| Operating Income | -1.86M |
| Pretax Income | -7.41M |
| Net Income | -7.19M |
| EBITDA | n/a |
| EBIT | -1.86M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 222,674 in cash and 11.44 million in debt, with a net cash position of -11.21 million or -0.34 per share.
| Cash & Cash Equivalents | 222,674 |
| Total Debt | 11.44M |
| Net Cash | -11.21M |
| Net Cash Per Share | -0.34 |
| Equity (Book Value) | -4.48M |
| Book Value Per Share | -0.14 |
| Working Capital | 2.01M |
Cash Flow
| Operating Cash Flow | -2.85M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 120,945 |
| Free Cash Flow | -2.85M |
| FCF Per Share | -0.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | 51,760.70% |
| Pretax Margin | 206,157.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:DOCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -110.66% |
| Shareholder Yield | -110.66% |
| Earnings Yield | -125.26% |
| FCF Yield | -49.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 30, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
CSE:DOCT has an Altman Z-Score of -6.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.76 |
| Piotroski F-Score | 2 |